Respiratory Syncytial Virus Infections

8 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Respiratory Syncytial Virus Infections
Treatment and conditionWhere it standsTrials
abrysvo for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
abrysvo + Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nirsevimab for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
RSVPreF3 OA investigational vaccine for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
S-337395 for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zelicapavir for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1